Citigroup’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.28K Sell
1,406
-126,696
-99% -$115K ﹤0.01% 4641
2025
Q1
$57.9K Buy
128,102
+6,249
+5% +$2.82K ﹤0.01% 4071
2024
Q4
$61.2K Buy
121,853
+11,664
+11% +$5.86K ﹤0.01% 4186
2024
Q3
$99.8K Buy
110,189
+74,095
+205% +$67.1K ﹤0.01% 3993
2024
Q2
$36K Buy
36,094
+10,241
+40% +$10.2K ﹤0.01% 4038
2024
Q1
$38.3K Buy
25,853
+2,022
+8% +$2.99K ﹤0.01% 4009
2023
Q4
$26K Sell
23,831
-109,220
-82% -$119K ﹤0.01% 4132
2023
Q3
$157K Sell
133,051
-25,720
-16% -$30.4K ﹤0.01% 3089
2023
Q2
$224K Sell
158,771
-304,113
-66% -$429K ﹤0.01% 3180
2023
Q1
$694K Sell
462,884
-14,290
-3% -$21.4K ﹤0.01% 2290
2022
Q4
$558K Buy
477,174
+341,193
+251% +$399K ﹤0.01% 2451
2022
Q3
$154K Buy
135,981
+131,050
+2,658% +$148K ﹤0.01% 3189
2022
Q2
$8K Sell
4,931
-4,106
-45% -$6.66K ﹤0.01% 4697
2022
Q1
$14K Sell
9,037
-26,570
-75% -$41.2K ﹤0.01% 4596
2021
Q4
$87K Sell
35,607
-102,251
-74% -$250K ﹤0.01% 4040
2021
Q3
$347K Buy
137,858
+126,195
+1,082% +$318K ﹤0.01% 3137
2021
Q2
$33K Buy
11,663
+3,527
+43% +$9.98K ﹤0.01% 4351
2021
Q1
$19K Buy
8,136
+2,245
+38% +$5.24K ﹤0.01% 4619
2020
Q4
$10K Hold
5,891
﹤0.01% 4872
2020
Q3
$6K Hold
5,891
﹤0.01% 4563
2020
Q2
$5K Sell
5,891
-31,219
-84% -$26.5K ﹤0.01% 4822
2020
Q1
$31K Buy
37,110
+2,935
+9% +$2.45K ﹤0.01% 4117
2019
Q4
$30K Buy
34,175
+18,577
+119% +$16.3K ﹤0.01% 4302
2019
Q3
$15K Sell
15,598
-16,733
-52% -$16.1K ﹤0.01% 4402
2019
Q2
$35K Sell
32,331
-2,117
-6% -$2.29K ﹤0.01% 4315
2019
Q1
$45K Buy
34,448
+5,933
+21% +$7.75K ﹤0.01% 4090
2018
Q4
$26K Sell
28,515
-4,601
-14% -$4.2K ﹤0.01% 4303
2018
Q3
$68K Buy
33,116
+451
+1% +$926 ﹤0.01% 3864
2018
Q2
$59K Buy
32,665
+1,726
+6% +$3.12K ﹤0.01% 3758
2018
Q1
$71K Buy
30,939
+15,052
+95% +$34.5K ﹤0.01% 3567
2017
Q4
$30K Buy
15,887
+12,845
+422% +$24.3K ﹤0.01% 4060
2017
Q3
$8K Buy
3,042
+1,870
+160% +$4.92K ﹤0.01% 4260
2017
Q2
$3K Sell
1,172
-1,972
-63% -$5.05K ﹤0.01% 4448
2017
Q1
$9K Sell
3,144
-78,259
-96% -$224K ﹤0.01% 4315
2016
Q4
$257K Buy
81,403
+73,455
+924% +$232K ﹤0.01% 3426
2016
Q3
$27K Sell
7,948
-1,770
-18% -$6.01K ﹤0.01% 4043
2016
Q2
$22K Sell
9,718
-45,361
-82% -$103K ﹤0.01% 4144
2016
Q1
$138K Buy
55,079
+33,998
+161% +$85.2K ﹤0.01% 3761
2015
Q4
$70K Buy
21,081
+20,860
+9,439% +$69.3K ﹤0.01% 3836
2015
Q3
$1K Sell
221
-1,020
-82% -$4.62K ﹤0.01% 5032
2015
Q2
$3K Sell
1,241
-2,808
-69% -$6.79K ﹤0.01% 5052
2015
Q1
$17K Sell
4,049
-9,102
-69% -$38.2K ﹤0.01% 4486
2014
Q4
$39K Buy
13,151
+9,663
+277% +$28.7K ﹤0.01% 4239
2014
Q3
$9K Buy
3,488
+2,736
+364% +$7.06K ﹤0.01% 4674
2014
Q2
$2K Sell
752
-6,320
-89% -$16.8K ﹤0.01% 5111
2014
Q1
$19K Sell
7,072
-15,053
-68% -$40.4K ﹤0.01% 4519
2013
Q4
$64K Buy
22,125
+21,598
+4,098% +$62.5K ﹤0.01% 4019
2013
Q3
$1K Sell
527
-244
-32% -$463 ﹤0.01% 5026
2013
Q2
$2K Buy
+771
New +$2K ﹤0.01% 4879